Provepharm's Corporate Minority Round

Provepharm raised a round of funding on April 27, 2018. Investors include Tethys Invest.

Provepharm provides pharmacopoeial grade methylene blue, a heterocyclic aromatic chemical compound.…

Articles about Provepharm's Corporate Minority Round: